Literature DB >> 20427784

Gaucher disease: spectrum of sonographic findings in the liver.

Irith Hadas-Halpern1, Maher Deeb, Ayala Abrahamov, Ari Zimran, Deborah Elstein.   

Abstract

OBJECTIVE: Our large tertiary clinic for patients with Gaucher disease has used sonography as the preferred modality to monitor hepatosplenomegaly in hundreds of patients for more than 18 years. With the advent of specific enzyme replacement therapy (ERT), sonographic monitoring of changes in both hepatomegaly and the echogenicity of the hepatic tissue may highlight features that are amenable to ERT.
METHODS: All patients (500) seen at presentation and at annual or semiannual routine visits have undergone sonographic examinations by a single senior radiologist (I.H.-H.).
RESULTS: Thirty-nine patients (7.8%) had sonographic evidence of hepatic disease (21 male and 18 female; age range, 18-90 years); 26 (66.7%) of these received ERT, and 10 (25.6%) were splenectomized.
CONCLUSIONS: Liver findings are relatively rare. Among 500 patients, there was no instance of computed tomographic findings that had not been previously shown by sonography. Radiologists should be acquainted with the variable sonographic spectrum of the Gaucher liver. If hepatic lesions are small, hyperechoic, and slowly evolving, one may surmise that they are due to Gaucher cell accumulation. However, special attention should be paid to progressive deterioration and irregularities in liver texture because other metabolic processes and cancers must be ruled out.

Entities:  

Mesh:

Year:  2010        PMID: 20427784     DOI: 10.7863/jum.2010.29.5.727

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  4 in total

1.  Gaucher disease in the liver on hepatocyte specific contrast agent enhanced MR imaging.

Authors:  Rama S Ayyala; Lisa A Teot; Jeanette M Perez Rossello
Journal:  Pediatr Radiol       Date:  2017-02-01

Review 2.  Mandibular and dental manifestations of Gaucher disease.

Authors:  H R Saranjam; E Sidransky; W Z Levine; A Zimran; D Elstein
Journal:  Oral Dis       Date:  2012-01-18       Impact factor: 3.511

Review 3.  Imaging of non-neuronopathic Gaucher disease: recent advances in quantitative imaging and comprehensive assessment of disease involvement.

Authors:  Andrew J Degnan; Victor M Ho-Fung; Rebecca C Ahrens-Nicklas; Christian A Barrera; Suraj D Serai; Dah-Jyuu Wang; Can Ficicioglu
Journal:  Insights Imaging       Date:  2019-07-10

4.  Liver involvement in patients with Gaucher disease types I and III.

Authors:  Rodrigo Tzovenos Starosta; Filippo Pinto E Vairo; Alícia Dorneles Dornelles; Suélen Porto Basgalupp; Marina Siebert; Maria Lúcia Alves Pedroso; Carlos Thadeu Schmidt Cerski; Mário Reis Álvares-da-Silva; Ida Vanessa Doederlein Schwartz
Journal:  Mol Genet Metab Rep       Date:  2020-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.